Is Sandoz Group AG a good investment? Sandoz Group AG (SDZ.SW) is currently trading at 65.20 CHF. Market analysts have a consensus price target of 70.31 CHF. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 38.68. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Sandoz Group AG is expected to release its next earnings report on Aug. 5, 2026. The market consensus estimate for Forward EPS is 3.71.
For income investors, Sandoz Group AG pays a dividend yield of 1.22%. With a payout ratio of 35%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.80 CHF (1.22% yield).
Sandoz Group AG is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Aug. 5, 2026. The company currently has a trailing EPS of 1.70.
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
| Year | Total Dividends |
|---|---|
| ▸2026 |
0.80 CHF
|
| April 15, 2026 | 0.8000 |
| ▸2025 |
0.60 CHF
|
| April 23, 2025 | 0.6000 |
| ▸2024 |
0.45 CHF
|
| May 7, 2024 | 0.4500 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Sandoz Group AG | Apr 15, 2026 | Paid | 0.8 CHF |
Community Discussion